| Field | Specification |
|---|---|
| Mfr No | |
| Accession Number | |
| Alternative Names | IPCA-7, PCANAP7, Prostate cancer-associated protein 7, SYT-7, SYT7, Synaptotagmin 7, Synaptotagmin VII, SytVII |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Host | |
| Immunogen | Fusion protein amino acids 150-239 (Cytoplasmic C2A domain) of mouse Synaptotagmin-7 |
| Isotype | |
| Product Type | |
| Reactivity | |
| Shipping | |
| Storage | |
| Target |
Synaptotagmin 7 (SYT7) is a member of the synaptotagmin family, a group of membrane-trafficking proteins characterized by an N-terminal transmembrane domain and two C-terminal C2 domains (C2A and C2B) that mediate calcium-dependent interactions. Among the 15 known mammalian synaptotagmins, SYT7 plays a distinct role in regulating synaptic vesicle exocytosis, asynchronous neurotransmitter release, and synaptic plasticity.
Unlike its counterparts that mediate fast, synchronous release, SYT7 is essential for sustained neurotransmission and vesicle replenishment during prolonged neuronal activity. It binds acidic phospholipids in a calcium-dependent manner and interacts with key synaptic proteins such as Stonin 2, neurexins, syntaxin, and AP2, influencing vesicle docking and fusion dynamics.
Recent studies implicate SYT7 in neurodegenerative disease mechanisms, including Alzheimer’s disease and Parkinson’s disease, where synaptic dysfunction and impaired vesicle trafficking are early pathological features. Altered SYT7 expression or function may disrupt calcium signaling, neurotransmitter release, and synaptic maintenance, contributing to cognitive decline and neuronal vulnerability.
Given its central role in calcium sensing and synaptic regulation, SYT7 is emerging as a promising target for therapeutic intervention in neurodegenerative disorders. Understanding SYT7’s molecular interactions and regulatory mechanisms is critical for advancing strategies aimed at preserving synaptic integrity and neuronal communication in aging and disease.
1 µg/ml of SMC-424 was sufficient for detection of Synaptotagmin-7 in 20 µg of rat brain lysate by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary antibody.
Cite this product varies by variant:
- SMC-424D — Size: 100 ug: Synaptotagmin-7 Antibody (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D, RRID: AB_2701379)
- SMC-424D-A390 — Size: 100 ug: Synaptotagmin-7 Antibody: ATTO 390 (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-A390, RRID: AB_2701380)
- SMC-424D-A488 — Size: 100 ug: Synaptotagmin-7 Antibody: ATTO 488 (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-A488, RRID: AB_2701381)
- SMC-424D-A594 — Size: 100 ug: Synaptotagmin-7 Antibody: ATTO 594 (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-A594, RRID: AB_2701383)
- SMC-424D-APC — Size: 100 ug: Synaptotagmin-7 Antibody: APC (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-APC, RRID: AB_2701389)
- SMC-424D-BI — Size: 100 ug: Synaptotagmin-7 Antibody: Biotin (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-BI, RRID: AB_2701390)
- SMC-424D-FITC — Size: 100 ug: Synaptotagmin-7 Antibody: FITC (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-FITC, RRID: AB_2701391)
- SMC-424D-HRP — Size: 100 ug: Synaptotagmin-7 Antibody: HRP (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-HRP, RRID: AB_2701392)
- SMC-424D-PCP — Size: 100 ug: Synaptotagmin-7 Antibody: PerCP (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-PCP, RRID: AB_2701394)
- SMC-424D-RPE — Size: 100 ug: Synaptotagmin-7 Antibody: RPE (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424D-RPE, RRID: AB_2701395)
- SMC-424S — Size: 12 ug: Synaptotagmin-7 Antibody (StressMarq Biosciences | Victoria, BC CANADA, Catalog# SMC-424S, RRID: AB_2701379)
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
2. Reichardt L.F., et al. (1981) J Cell Biol. 91:257.